Botulism is a neuroparalytic illness resulting from the action of a potent toxin produced by the organism Clostridium botulinum. It can present with a classic triad of clear mentation, bulbar palsy and symmetric descending paralysis. Treatment is symptomatic and includes a botulinum antitoxin.
Richard S. Cassa is a chief PA in the Department of Neurology, Division of Acute Neurosciences at New York Presbyterian Hospital-Cornell in New York City. Axel J. Rosengart is director of neurocritical care and an associate professor of neurology, neuroscience, and neurosurgery at Weill Cornell Medical College in New York City.The authors have disclosed no potential conflicts of interest, financial or otherwise.